Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNom chimique: N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-aspartic acid beta-(5-butylnon-5-yl) ester // Synonymes: Fmoc-Asp(OBno)-OH, N-alpha-Fmoc-(O-5-(n-butyl)-non-5-yl)aspartic acid, (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-((5-butylnonan-5-yl)oxy)-4-oxobutanoic acid,Fmoc-Asp(OBno)-OH
from 430,00 €
An extremely effective derivative for minimizing aspartimide formation during Fmoc SPPS of Asp-containing peptides. The bulky OBno protecting group provides considerably more protection against the formation of aspartimide-related by-products than the commonly used OtBu and OMpe groups.
Preventing aspartimide formation in Fmoc SPPS of Asp-Gly containing peptides - practical aspects of new trialkylcarbinol based protecting groups. Raymond Behrendt, Simon Huber, Peter White; J. Pept. Sci. 2016; 22(2):, 92-97. DOI:10.1002/psc.2844
New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS. Raymond Behrendt, Simon Huber, Roger Marti, Peter White. J. Pept. Sci. 2015; 21(8):, 680-687. DOI:10.1002/psc.2790
Patent EP 2 886 531 B1
Veuillez m'envoyer plus d'informations sur